Saint Louis University Institute for Drug and Biotherapeutic Innovation Hosting Research Symposium

07/21/2022

The Saint Louis University Institute for Drug and Biotherapeutic Innovation invites the University community to its inaugural research symposium.

The event will be held from 1 p.m. to 5 p.m.  on Friday, Sept. 23, at the COLLAB@Cortex  located at 4220 Duncan Ave.

All University faculty, staff, and trainees with an interest in drug and biotherapeutic discovery, development, delivery, and translation are invited to attend. Registration is free, but required to attend.

Trainees of all levels are invited to submit an abstract for inclusion as a poster or oral presentation:
Abstract submission details can be found online. 

The deadline to submit an abstract is Tuesday, Aug. 9, by 11:59 p.m.

The symposium will feature:

• Keynote address from Shaun Stauffer, Ph.D., Director of the Cleveland Clinic Center for Therapeutics Discovery
• Oral presentations from trainees
• Poster presentations from trainees
• Social gathering

Questions about the research symposium can be sent to jaffre.athman@slu.edu.

The Saint Louis University Institute for Drug and Biotherapeutic Innovation (SLU-IDBI) is a multidisciplinary association of researchers with a shared interest in drug and biotherapeutic discovery and development to address unmet patient needs.

All University associated faculty, staff, and trainees with an interest in therapeutic discovery, development, and translation are invited to join the IDBI by contacting John Tavis, Director (john.tavis@health.slu.edu).

More information on the IDBI can be found on the Institute website.